Elite in Nonalcoholic Steatohepatitis (NASH)
Check Dr. Mary E. Rinella's experience treating your condition:
About Dr. Mary E. Rinella

Mary Rinella is a Gastroenterologist in Chicago, Illinois. Rinella has been practicing medicine for over 26 years and is rated as an Elite expert by MediFind in the treatment of Nonalcoholic Steatohepatitis (NASH). She is also highly rated in 25 other conditions, according to our data. Her top areas of expertise are Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Cirrhosis, Liver Transplant, and Endoscopy. She is licensed to treat patients in Illinois. Rinella is currently accepting new patients.

Her clinical research consists of co-authoring 101 peer reviewed articles and participating in 11 clinical trials in the past 15 years. In particular, she has co-authored 82 articles and participated in 10 clinical trials in the study of Nonalcoholic Steatohepatitis (NASH).


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Mary E. Rinella it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
5758 S Maryland Ave, Chicago, IL 60637
Other Locations
355 E Grand Ave, Chicago, IL 60611
Background & Education
Graduate Institution
Other, 1996
Internal Medicine in IL
Hospital Affiliations
Franciscan Health Crown Point
Northwestern Medicine Lake Forest Hospital
Northwestern Medicine McHenry Hospital
Evanston Hospital
UChicago Medicine Mitchell Hospital
Northwestern Medicine Central DuPage Hospital
Northwestern Memorial Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
The Effect of Pentoxifylline on Nonalcoholic Steatohepatitis (NASH)
View 10 Less Clinical Trials -

101 Total Publications

The Cost of Diagnosing and Managing Non-alcoholic Steatohepatitis in Europe and the United States.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors